Contact
searchSearch
HMP Global

Health Care Economics

Pratt Headshot
Commentary
Time: The Critical Resource Rural Hospitals Can’t Afford to Waste
09/26/2025
Mark Pratt
Rural health care staff members don’t just wear many hats—they often wear them all at once. In many communities, one person might be handling registration, billing, and collections while also answering phones or covering a front desk. When...
Rural health care staff members don’t just wear many hats—they often wear them all at once. In many communities, one person might be handling registration, billing, and collections while also answering phones or covering a front desk. When...
Rural health care staff members...
09/26/2025
First Report Managed Care
Hero Image
News
‘First Report Managed Care’ Webinar to Address Specialty Pharmacy Disruption, Cost Pressures, and Patient Access
09/24/2025
Danielle Sposato
Rising specialty drug costs, surging demand for GLP-1 therapies, and ongoing supply chain and policy challenges are putting patient access at risk. To address these pressures, First Report Managed Care will host a complimentary 60-minute...
Rising specialty drug costs, surging demand for GLP-1 therapies, and ongoing supply chain and policy challenges are putting patient access at risk. To address these pressures, First Report Managed Care will host a complimentary 60-minute...
Rising specialty drug costs,...
09/24/2025
First Report Managed Care
News
Managed Care Insurers Brace for Q2 Declines Amid Policy Shifts and Rising Costs
07/17/2025
Grace Taylor, MS, MA
Most major US health insurers are expected to report lower Q2 earnings as rising Medicare Advantage costs and looming Medicaid policy changes weigh heavily on financial performance.
Most major US health insurers are expected to report lower Q2 earnings as rising Medicare Advantage costs and looming Medicaid policy changes weigh heavily on financial performance.
Most major US health insurers...
07/17/2025
First Report Managed Care
Conference Coverage
Strategies for Optimizing Free Drug Programs in a Changing Policy Landscape
04/29/2025
Juliet Gallagher
At Asembia 2025, experts from AcariaHealth detailed how strategic management of free drug programs can optimize outcomes for manufacturers and patients alike, while adapting to evolving regulatory and payer environments.
At Asembia 2025, experts from AcariaHealth detailed how strategic management of free drug programs can optimize outcomes for manufacturers and patients alike, while adapting to evolving regulatory and payer environments.
At Asembia 2025, experts from...
04/29/2025
First Report Managed Care
Conference Coverage
Balancing Innovation and Access: Managed Care Strategies to Navigate the Rising Cost of Oncology Treatments
04/24/2025
Grace Taylor, MS, MA
As oncology treatments grow more advanced and expensive, a panel of experts at AMCP 2025 reveal how managed care strategies are evolving to ensure both cost control and high-quality patient outcomes.
As oncology treatments grow more advanced and expensive, a panel of experts at AMCP 2025 reveal how managed care strategies are evolving to ensure both cost control and high-quality patient outcomes.
As oncology treatments grow more...
04/24/2025
First Report Managed Care
Managed Care Q&A
2025 Drugs to Watch: Market Access, Innovation, and the Future of Reimbursement
02/28/2025
John Stahl; Roy Moore
In this interview, guest experts John Stahl and Roy Moore explore the evolving payer landscape in 2025, discussing the growing role of value-based agreements, real-world evidence, and innovative reimbursement models in supporting the adoption...
In this interview, guest experts John Stahl and Roy Moore explore the evolving payer landscape in 2025, discussing the growing role of value-based agreements, real-world evidence, and innovative reimbursement models in supporting the adoption...
In this interview, guest experts...
02/28/2025
First Report Managed Care
News
Study Finds At-Risk Medicare Advantage Plans Lead in Quality and Efficiency
02/11/2025
Juliet Gallagher
A recent study published in JAMA Network Open provides evidence that at-risk Medicare Advantage (MA) payment arrangements lead to superior quality and efficiency in health care delivery compared with fee-for-service (FFS) MA models.
A recent study published in JAMA Network Open provides evidence that at-risk Medicare Advantage (MA) payment arrangements lead to superior quality and efficiency in health care delivery compared with fee-for-service (FFS) MA models.
A recent study published in JAMA...
02/11/2025
First Report Managed Care
News
90% ROI on Mental Health Benefits
02/07/2025
Juliet Gallagher
A recent study published in JAMA Network Open highlights the financial benefits of employer-sponsored behavioral health programs, demonstrating that these programs can result in significant net medical costs savings.
A recent study published in JAMA Network Open highlights the financial benefits of employer-sponsored behavioral health programs, demonstrating that these programs can result in significant net medical costs savings.
A recent study published in JAMA...
02/07/2025
First Report Managed Care
News
Biosimilar Competition Reduces Adalimumab Spending but Faces Challenges in Uptake
01/20/2025
Lisa Kuhns, PhD, MD
In the first year of biosimilar competition for adalimumab, spending on the drug decreased by nearly 50%, yet biosimilars accounted for less than 2% of prescriptions in the US.
In the first year of biosimilar competition for adalimumab, spending on the drug decreased by nearly 50%, yet biosimilars accounted for less than 2% of prescriptions in the US.
In the first year of biosimilar...
01/20/2025
First Report Managed Care
Headshots
Commentary
How to Maximize the Value of GLP-1 Drugs While Improving Health Equity
01/14/2025
Julie Schulz, MD, MPH; Michael Dovidio, PharmD
GLP-1 drugs present significant financial and health equity challenges, offering transformative benefits for obesity and cardiometabolic disorders while requiring data-driven strategies for cost-effective and equitable access.
GLP-1 drugs present significant financial and health equity challenges, offering transformative benefits for obesity and cardiometabolic disorders while requiring data-driven strategies for cost-effective and equitable access.
GLP-1 drugs present significant...
01/14/2025
First Report Managed Care
Expert Perspectives
Commentary Videos

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use